Novartis AG
COMPOSITIONS AND METHODS TO TREAT CANCER

Last updated:

Abstract:

The disclosure provides novel personalized therapies, kits, transmittable forms of information and methods for use in treating patients having cancer, wherein the cancer is amenable to therapeutic treatment with an inhibitor, e.g., an inhibitor of any of the targets disclosed herein. Kits, methods of screening for candidate inhibitors, and associated methods of treatment are also provided.

Status:
Application
Type:

Utility

Filling date:

20 Jul 2018

Issue date:

27 May 2021